Autosomal dominant tubulointerstitial kidney disease due to REN mutations

How is autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN) diagnosed?

The diagnosis of autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN) is made based on the symptoms, specific laboratory testing, a family history of kidney disease or gout, and genetic testing.

Last updated on 05-01-20

How is autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN) inherited?

Autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN) is inherited in an autosomal dominant pattern. All individuals inherit two copies of each gene. In autosomal dominant conditions, having a mutation in just one copy of the REN gene causes the person to have the disease. Some people are born with an autosomal dominant condition due to a new genetic mutation (de novo) and do not have a history of this condition in their family. There is nothing either parent can do, before or during pregnancy, to cause a child to have this.

Each child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the REN mutation and ADTKD-REN. Children who inherit the REN mutation will have ADTKD-REN. They may be more or less severely affected than their parent.

Last updated on 05-01-20

What is the long-term outlook for people with autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN)?

The long-term outlook for people with autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN) is good, though patients will often need a kidney transplant or start dialysis between the ages of 40 and 80. At this point, it is difficult to predict at what age patients will develop end-stage kidney failure.

Last updated on 05-01-20

How many people have autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN)?

Autosomal dominant tubulointerstitial kidney disease due to REN mutations (ADTKD-REN) is very rare, with less than 20 families reported worldwide.

Last updated on 05-01-20

How might autosomal dominant tubule-interstitial kidney disease due to REN mutations (ADTKD-REN) be treated?

Treatment for autosomal dominant tubule-interstitial kidney disease due to REN mutations (ADTKD-REN) is based on managing the symptoms. The medication erythropoietin is very effective in treating the anemia that occurs in childhood. Gout can also be prevented with medications such as allopurinol or febuxostat. Fludrocortisone has been shown to improve low blood pressure and high potassium levels in ADTKD-REN and theoretically may slow progression of ADTKD-REN. Eventually, patients may need a kidney transplant or dialysis. Live donor kidney transplantation is the optimal treatment for worsening kidney disease, and patients who undergo kidney transplant for this condition do extremely well. The condition does not come back in the transplanted kidney.

Last updated on 05-01-20

Name: Rare Inherited Kidney Disease Team Wake Forest School of Medicine Medical Center Boulevard
Winston-Salem, NC, 27157,
Email: kidney@wakehealth.edu
Name: Wake Forest School of Medicine Rare Inherited Kidney Disease Team Medical Center Blvd.
Winston-Salem, NC, 27157,
Email: kidney@wakehealth.edu
Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O. Kidney Disease: Improving Global Outcomes. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report Kidney Int. Oct 2015; 88(4). 676-683. Reference Link Kmoch S, Zivna M, Bleyer AJ. Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related GeneReviews. Updated Dec. 29, 2015; Reference Link Autosomal dominant tubule-interstitial kidney disease National Organization for Rare Disorders (NORD). Updated 2017; Reference Link REN-related kidney disease Genetics Home Reference (GHR). Jan 2010; Reference Link

Note, these links are external searches against the National Laboratory of Medicine's drug database. You may need to adjust the search if there are no results found.

Drug Name Generic Name
Jynarque tolvaptan

Connect with other users with Autosomal dominant tubulointerstitial kidney disease due to REN mutations on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App